| Net income | 212K |
| Depreciation and amortization | 21K |
| Share-based compensation | 276K |
| Realized gain on securities | -53K |
| Income tax receivable | 44K |
| Tax liabilities | 21K |
| Effects of liquidation of subsidiary | -42K |
| Trade accounts receivables | 1.42M |
| Prepaid expenses and other assets | -11K |
| Accounts payable | 0 |
| Accrued product licensing costs | -418K |
| Deferred revenue | 0 |
| Income taxes payable | -170K |
| Other liabilities | 0 |
| Net cash provided by operating activities | 1.3M |
| Purchases of marketable securities | -457K |
| Proceeds from sale of securities | 69K |
| Net cash provided (used in) by investing activities | -388K |
| Purchase of employee stock option | -22K |
| Proceeds from exercise of common stock options | 122K |
| Net cash provided by financing activities | 100K |
| Net increase in cash and cash equivalents | 1.01M |
| Cash and cash equivalents, beginning of period | 12.38M |
| Cash and cash equivalents, end of period | 13.4M |